ArticleJournal of cannabis research2026
Commentary: Methodological considerations in the interpretation of evidence on cannabis-based medicines for chronic neuropathic pain.
Article in Journal of cannabis research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Recent systematic reviews, including a Cochrane review, have concluded that the certainty of evidence supporting the use of cannabis-based medicines for chronic neuropathic pain remains low. While this overall conclusion is reasonable, its interpretation warrants careful scrutiny. In this commentary, key methodological and interpretative aspects relevant to the appraisal of this evidence base are examined, with particular attention to the application of the GRADE framework, clinical heterogeneity, outcome selection, and indirectness. It is proposed that inconsistent or insufficiently transparent application of methodological criteria may influence how results are interpreted and communicated, with potential implications for clinical decision-making. A cautious, consistent, and context-aware interpretation of the available evidence is essential to avoid both overstatement and undue dismissal of therapeutic effects in a complex and heterogeneous condition such as neuropathic pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.